Report Summary
Eternity Insights has published a new study on Global Biobanking Equipment Market focusing on key segments as by Type (Blood Products,Human Tissues,Cell Lines,Nucleic Acids), by Application (Regenerative Medicine,Life Science,Clinical Research, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Biobanking Equipment Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Biobanking Equipment Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Biobanking Equipment Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Biobanking Equipment Market Segmentation:
Biobanking Equipment Market, By Type
- Blood Products
- Human Tissues
- Cell Lines
- Nucleic Acids
Biobanking Equipment Market, By Application
- Regenerative Medicine
- Life Science
- Clinical Research
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Biobanking Equipment market in terms of demand generation. The Biobanking Equipment market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Biobanking Equipment market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Biobanking Equipment Market Taxonomy:
To learn more about this report
Global Biobanking Equipment Market Competitive Landscape
The global Biobanking Equipment market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Thermo Fisher Scientific Inc. (US)
- Qiagen N.V. (Germany)
- Hamilton Company (US)
- Brooks Automation (US)
- Worthington Industries (US)
- Becton
- Dickinson and Company (US)
- Merck KGaA (Germany)
- Micronic (Netherlands)
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Blood Products,Human Tissues,Cell Lines,Nucleic Acids |
| By Application Outlook |
Regenerative Medicine,Life Science,Clinical Research, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Thermo Fisher Scientific Inc. (US),Qiagen N.V. (Germany),Hamilton Company (US),Brooks Automation (US),Worthington Industries (US),Becton,Dickinson and Company (US),Merck KGaA (Germany),Micronic (Netherlands) |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Biobanking Equipment Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Biobanking Equipment Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Blood Products Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Human Tissues Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Cell Lines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.4 Nucleic Acids Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Biobanking Equipment Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Biobanking Equipment Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Biobanking Equipment Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Biobanking Equipment Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Biobanking Equipment Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Biobanking Equipment Market Assessment by Type
8.1 Asia Pacific Biobanking Equipment Market Assessment by Application (Consumption and Market Share)
8.2 North America Biobanking Equipment Market Assessment by Application (Consumption and Market Share)
8.3 Europe Biobanking Equipment Market Assessment by Application (Consumption and Market Share)
8.4 South America Biobanking Equipment Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Biobanking Equipment Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Thermo Fisher Scientific Inc. (US)
9.1.1 Thermo Fisher Scientific Inc. (US) Profiles
9.1.2 Thermo Fisher Scientific Inc. (US) Product Portfolio
9.1.3 Thermo Fisher Scientific Inc. (US) Biobanking Equipment Business Performance
9.1.4 Thermo Fisher Scientific Inc. (US) Biobanking Equipment Business Development and Market Status
9.2 Qiagen N.V. (Germany)
9.2.1 Qiagen N.V. (Germany) Profiles
9.2.2 Qiagen N.V. (Germany) Product Portfolio
9.2.3 Qiagen N.V. (Germany) Biobanking Equipment Business Performance
9.2.4 Qiagen N.V. (Germany) Biobanking Equipment Business Development and Market Status
9.3 Hamilton Company (US)
9.3.1 Hamilton Company (US) Profiles
9.3.2 Hamilton Company (US) Product Portfolio
9.3.3 Hamilton Company (US) Biobanking Equipment Business Performance
9.3.4 Hamilton Company (US) Biobanking Equipment Business Development and Market Status
9.4 Brooks Automation (US)
9.4.1 Brooks Automation (US) Profiles
9.4.2 Brooks Automation (US) Product Portfolio
9.4.3 Brooks Automation (US) Biobanking Equipment Business Performance
9.4.4 Brooks Automation (US) Biobanking Equipment Business Development and Market Status
9.5 Worthington Industries (US)
9.5.1 Worthington Industries (US) Profiles
9.5.2 Worthington Industries (US) Product Portfolio
9.5.3 Worthington Industries (US) Biobanking Equipment Business Performance
9.5.4 Worthington Industries (US) Biobanking Equipment Business Development and Market Status
9.6 Becton
9.6.1 Becton Profiles
9.6.2 Becton Product Portfolio
9.6.3 Becton Biobanking Equipment Business Performance
9.6.4 Becton Biobanking Equipment Business Development and Market Status
9.7 Dickinson and Company (US)
9.7.1 Dickinson and Company (US) Profiles
9.7.2 Dickinson and Company (US) Product Portfolio
9.7.3 Dickinson and Company (US) Biobanking Equipment Business Performance
9.7.4 Dickinson and Company (US) Biobanking Equipment Business Development and Market Status
9.8 Merck KGaA (Germany)
9.8.1 Merck KGaA (Germany) Profiles
9.8.2 Merck KGaA (Germany) Product Portfolio
9.8.3 Merck KGaA (Germany) Biobanking Equipment Business Performance
9.8.4 Merck KGaA (Germany) Biobanking Equipment Business Development and Market Status
9.9 Micronic (Netherlands)
9.9.1 Micronic (Netherlands) Profiles
9.9.2 Micronic (Netherlands) Product Portfolio
9.9.3 Micronic (Netherlands) Biobanking Equipment Business Performance
9.9.4 Micronic (Netherlands) Biobanking Equipment Business Development and Market Status
10 World Biobanking Equipment Market Assessment by Players
10.1 Global Biobanking Equipment Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Biobanking Equipment Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Biobanking Equipment Price (USD/Unit) of Players 2014-2020
10.4 Global Biobanking Equipment Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Biobanking Equipment Sales Assessment of Players 2014-2020
11.1.2 North America Biobanking Equipment Revenue Assessment of Players 2014-2020
11.1.3 North America Biobanking Equipment Price Assessment of Players 2014-2020
11.1.4 North America Biobanking Equipment Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Biobanking Equipment Sales Assessment of Players 2014-2020
11.2.2 Europe Biobanking Equipment Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Biobanking Equipment Price Assessment of Players 2014-2020
11.2.4 Europe Biobanking Equipment Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Biobanking Equipment Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Biobanking Equipment Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Biobanking Equipment Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Biobanking Equipment Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Biobanking Equipment Sales Assessment of Players 2014-2020
11.4.2 South America Biobanking Equipment Revenue Assessment of Players 2014-2020
11.4.3 South America Biobanking Equipment Price Assessment of Players 2014-2020
11.4.4 South America Biobanking Equipment Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Biobanking Equipment Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Biobanking Equipment Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Biobanking Equipment Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Biobanking Equipment Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Biobanking Equipment Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Biobanking Equipment Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Biobanking Equipment Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Biobanking Equipment Sales by Countries/Regions 2014-2020
12.2.2 North America Biobanking Equipment Revenue by Countries/Regions 2014-2020
12.2.3 North America Biobanking Equipment Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Biobanking Equipment Sales by Countries/Regions 2014-2020
12.3.2 Europe Biobanking Equipment Revenue by Countries/Regions 2014-2020
12.3.3 Europe Biobanking Equipment Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Biobanking Equipment Sales by Countries/Regions 2014-2020
12.4.2 South America Biobanking Equipment Revenue by Countries/Regions 2014-2020
12.4.3 South America Biobanking Equipment Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Biobanking Equipment Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Biobanking Equipment Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Biobanking Equipment Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Biobanking Equipment Sales & Revenue Forecast 2021-2026
14.1 World Biobanking Equipment Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Biobanking EquipmentSales and Market Share by Regions
14.1.2 World Biobanking EquipmentRevenue and Market Share by Regions
15 Asia Biobanking Equipment Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Blood Products
15.1.2 Human Tissues
15.1.3 Cell Lines
15.1.4 Nucleic Acids
15.2 Consumption Forecast by Application, 2021-2026
16 North America Biobanking Equipment Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Blood Products
16.1.2 Human Tissues
16.1.3 Cell Lines
16.1.4 Nucleic Acids
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Biobanking Equipment Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Blood Products
17.1.2 Human Tissues
17.1.3 Cell Lines
17.1.4 Nucleic Acids
17.2 Consumption Forecast by Application, 2021-2026
18 South America Biobanking Equipment Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Blood Products
18.1.2 Human Tissues
18.1.3 Cell Lines
18.1.4 Nucleic Acids
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Biobanking Equipment Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Blood Products
19.1.2 Human Tissues
19.1.3 Cell Lines
19.1.4 Nucleic Acids
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Biobanking Equipment Price (USD/Unit) Trend 2021-2026
20.2 Global Biobanking Equipment Gross Profit Trend 2021-2026
21 Conclusion
